Rasagiline
Last Updated: 09/19/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 785 publications
Comparative Efficacy and Safety of Treatments for Parkinson's Disease With Depression: A Systematic Review and Bayesian Model-Based Network Meta-Analysis.
Journal: Brain and behavior
Published: August 26, 2026
Span60/Cholesterol Niosomal Formulation as a Transport Vehicle for L-DOPA and Rasagiline Delivery with Potent In Vitro Neuroprotective Effect.
Journal: Applied biochemistry and biotechnology
Published: August 10, 2026
Sex-Specific Association of Rasagiline with Motor Progression in GBA1-Associated Parkinson's Disease.
Journal: Life (Basel, Switzerland)
Published: June 05, 2026
Correction: Case Report: A possible novel adult-onset, progressive MAO-A hypofunction.
Journal: Frontiers in neuroscience
Published: June 05, 2026
A successful switch from rasagiline to safinamide in a 49-year-old female with early-onset Parkinson's disease: a case report and review of literature.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: March 17, 2026
Dopamine-Enhancing Therapies and Risk of Neovascular AMD Conversion: A Target Trial Emulation.
Journal: American journal of ophthalmology
Published: March 10, 2026
The path to diagnosis of unexplained severe hyperchloremia: a case of corrosive substance ıngestion and early hemodialysis.
Journal: Irish journal of medical science
Published: February 21, 2026
Fatigue in Parkinson's disease and management with NIBS.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: February 12, 2026
An In Vivo Single-Vesicle Electrochemistry Enables Monitoring Vesicular Dopamine Dynamics and Pharmacological Rescue.
Journal: Angewandte Chemie (International ed. in English)
Published: February 02, 2026
Last Updated: 09/19/2026